Patents by Inventor Michael Lloyd Radomsky

Michael Lloyd Radomsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220387416
    Abstract: This disclosure relates to stable formulations of atropine and scopolamine for use as a medical countermeasure to combat organophosphate nerve agent threats. The formulations exploit complementary pharmacological profiles for optimal receptor blockade and anticholinergic activity within the peripheral and central nervous system. The formulations are suitable for intramuscular injection, and have stability that exceeds two years in stressed conditions.
    Type: Application
    Filed: October 26, 2020
    Publication date: December 8, 2022
    Inventors: Michael Lloyd RADOMSKY, Donald DUWE
  • Patent number: 5977070
    Abstract: A pharmaceutical composition for the nasal delivery of compounds useful for treating osteoporosis, comprising an effective amount of a physiologically active truncated analog of PTH or PTHrp, or salt thereof, in which amino acid residues (22-31) form an amphipathic .alpha.-helix, said residues (22-31) selected from (SEQ ID NOS: 85, 86, 26, 27, 28, 29, and 30); an absorption enhancer selected from the group consisting of dimethyl-.beta.-cyclodextrin and the bile acid surfactants; and water is provided.
    Type: Grant
    Filed: August 29, 1995
    Date of Patent: November 2, 1999
    Inventors: Christin Teresa Piazza, Michael Lloyd Radomsky, John Leonard Krstenansky, John Joseph Nestor, Jr., Brian Henry Vickery